 The primary objective of this pilot study is to evaluate the safety and efficacy of direct instillations of Botulinum-A toxinDMSO into the bladder via a catheter system as a means of treating women with symptoms of overactive bladder and secondary urinary incontinence. In doing so, we will focus on estimating the percentage of women who experience an improvement in their urinary incontinence symptoms at one month and three months following this novel instillation technique. 